iomeprol has been researched along with Liver Steatosis in 2 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fatty liver was assessed by means of an attenuation of -10 HU or higher (calculated as liver attenuation minus spleen attenuation) by using computed tomography (CT), coronary plaques and stenosis by using CT coronary angiography, and biomarkers of insulin resistance, lipotoxicity, systemic inflammation, and oxidant and antioxidant status." | 1.36 | Presence of coronary plaques in patients with nonalcoholic fatty liver disease. ( Assy, N; Djibre, A; Farah, R; Grosovski, M; Marmor, A, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assy, N | 1 |
| Djibre, A | 1 |
| Farah, R | 1 |
| Grosovski, M | 1 |
| Marmor, A | 1 |
| Laghi, F | 1 |
| Catalano, O | 1 |
| Maresca, M | 1 |
| Sandomenico, F | 1 |
| Siani, A | 1 |
2 other studies available for iomeprol and Liver Steatosis
| Article | Year |
|---|---|
Presence of coronary plaques in patients with nonalcoholic fatty liver disease.
Topics: Biomarkers; Case-Control Studies; Contrast Media; Coronary Angiography; Coronary Artery Disease; Fat | 2010 |
Indeterminate, subcentimetric focal liver lesions in cancer patients: additional role of contrast-enhanced ultrasound.
Topics: Adult; Contrast Media; Cysts; Diagnosis, Differential; Fatty Liver; Female; Follow-Up Studies; Heman | 2010 |